SCHEMBL5998809

SCHEMBL5998809

CC(=O)SCC(=O)NCCCCCC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 14/20 0.77
HDAC3 O15379 13/20 0.77
HDAC4 P56524 13/20 0.77
HDAC1 Q13547 13/20 0.77
HDAC7 Q8WUI4 13/20 0.77
HDAC2 Q92769 13/20 0.77
HDAC10 Q969S8 13/20 0.77
HDAC11 Q96DB2 13/20 0.77
HDAC6 Q9UBN7 13/20 0.77
HDAC9 Q9UKV0 13/20 0.77
HDAC5 Q9UQL6 13/20 0.77
ALDH1A1 P00352 2/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TRPV1 Q8NER1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8272561 0.89 HDAC3 (0.79) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL5999674 0.88 HDAC8 (0.77) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL8272148 0.88 HDAC8 (0.77) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL6000067 0.88 HDAC3 (0.77) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL5998508 0.87 HDAC1 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL5999381 0.87 HDAC3 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL5998473 0.86 HDAC1 (0.76) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL6000032 0.85 HDAC1 (0.74) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL8228208 0.85 HDAC1 (0.86) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL5999028 0.85 HDAC1 (0.74) HDAC8HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006028972-A2 MERCAPTOAMIDES AS HISTONE DEACETYLASE INHIBITORS OSI PHARMACEUTICALS, INC. (US) 2006-03-16 WO disclosed
US-20060047123-A1 Mercaptoamides as histone deacetylase inhibitors AHMED SALEH 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047123-A1 Mercaptoamides as histone deacetylase inhibitors HDAC1, HDAC11, HDAC2 HDAC8 10/4885HDAC3 7/4885HDAC4 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.